Dr. Robert Sindelar was appointed Vice President of Research & Academic Affairs at Providence Health Care, President of the Providence Health Care Research Institute and Associate Dean Research in the University of British Columbia (UBC) Faculty of Medicine in 2013. He is also Professor and Former Dean, the UBC Faculty of Pharmaceutical Sciences. In these roles, Dr. Sindelar oversees the research enterprise at Providence as well as strategic and operational collaborations with the universities.
Dr. Sindelar completed a MS degree in 1975 and a PhD in Medicinal Chemistry and Natural Products in 1980 at the University of Iowa. His research expertise is in medicinal chemistry, computer-aided drug discovery, and pharmaceutical biotechnology. His research on the immune system and related diseases resulted in approximately $14 million in extramural funding, 60+ journal articles, six U.S. patents, several international patents, and over 125 invited presentations. Dr. Sindelar is the recipient of several School and University-wide teaching honors and is a fellow of the Canadian Academy of Health Sciences.
While serving as Dean at UBC, he was instrumental in the fundraising, design and building of a new 250,000 sqft building that has won numerous awards for design, functionality and innovation. He has taught in the professional and graduate curriculum and serves on scientific advisory and editorial boards. In addition, he is a founder of the Centre for Drug Research and Development (CDRD), a national not-for-profit drug development and commercialization centre that provides expertise and infrastructure to enable researchers to advance promising early-stage drug candidates.